Abstract:Background and purpose: Cerebral ischemia/reperfusion is associated with reactive oxygen species (ROS) generation, and NADPH oxidases are important sources of ROS. We hypothesized that NADPH oxidases mediate blood-brain barrier (BBB) disruption and contribute to tissue damage in ischemia/reperfusion. Methods: Ischemia was induced by filament occlusion of the middle cerebral artery in mice for 2 hours followed by reperfusion. BBB permeability was measured by Evans blue extravasation. Monolayer permeability was determined from transendothelial electrical resistance of cultured porcine brain capillary endothelial cells. Results: BBB permeability was increased in the ischemic hemisphere 1 hour after reperfusion. In NADPH oxidase-knockout (gp91phox(-/-)) mice, middle cerebral artery occlusion-induced BBB disruption and lesion volume were largely attenuated compared with those in wild-type mice. Inhibition of NADPH oxidase by apocynin prevented BBB damage. In porcine brain capillary endothelial cells, hypoxia/reoxygenation induced translocation of the NADPH oxidase activator Rac-1 to the membrane. In vivo inhibition of Rac-1 by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin or Clostridium difficile lethal toxin B also prevented the ischemia/reperfusion-induced BBB disruption. Stimulation of porcine brain capillary endothelial cells with H(2)O(2) increased permeability, an effect attenuated by inhibition of phosphatidyl inositol 3-kinase or c-Jun N-terminal kinase but not blockade of extracellular signal-regulated kinase-1/2 or p38 mitogen-activated protein kinase. Inhibition of Rho kinase completely prevented the ROS-induced increase in permeability and the ROS-induced polymerization of the actin cytoskeleton. Conclusions: Activation of Rac and subsequently of the gp91phox containing NADPH oxidase promotes cerebral ROS formation, which then leads to Rho kinase-mediated endothelial cell contraction and disruption of the BBB. Inhibition of NADPH oxidase is a promising approach to reduce brain injury after stroke.

NADPH Oxidase: A Potential Target for Treatment of Stroke

NADPH oxidase and cerebral ischemia-reperfusion injury

Pathophysiology and Therapeutic Potential of NADPH Oxidases in Ischemic Stroke-Induced Oxidative Stress.

Oxidative Injury in Ischemic Stroke: A Focus on NADPH Oxidase 4

Neuroprotection after stroke by targeting NOX4 as a source of oxidative stress

Role of NADPH Oxidases in Oxidative Stress after Ischemic Stroke

Role of NADPH Oxidases in Stroke Recovery

Reactive Oxygen Species-Responsive Nanotherapy for the Prevention and Treatment of Cerebral Ischemia–reperfusion Injury

Which NADPH oxidase isoform is relevant for ischemic stroke? The case for nox 2

Potential Neuroprotective Treatment of Stroke: Targeting Excitotoxicity, Oxidative Stress, and Inflammation

Targeting Nitrosative Stress as a Therapeutic Strategy for Neurovascular Protection in Brain Ischemia

Utilizing reactive oxygen species-scavenging nanoparticles for targeting oxidative stress in the treatment of ischemic stroke: A review

Targeting nitrosative stress for neurovascular protection: new implications in brain diseases.

NADPH Oxidases in the Central Nervous System: Regional and Cellular Localization and the Possible Link to Brain Diseases

NADPH oxidase plays a central role in blood-brain barrier damage in experimental stroke

NADPH Oxidases: Novel Therapeutic Targets for Neurodegenerative Diseases

The role of oxidative stress in blood–brain barrier disruption during ischemic stroke: Antioxidants in clinical trials

Oxidative Stress and Its Role in the Pathogenesis of Ischaemic Stroke

Combined NADPH and the NOX Inhibitor Apocynin Provides Greater Anti-Inflammatory and Neuroprotective Effects in a Mouse Model of Stroke

Polyphenols for Stroke Therapy: the Role of Oxidative Stress Regulation

The Role of Oxidative Stress in Acute Ischemic Stroke-Related Thrombosis